本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kronos Bio, Inc.

0.8800
0.0000
成交量:- -
成交额:- -
市值:5,372.52万
市盈率:-0.82
高:0.8800
开:0.8800
低:0.8800
收:0.8800
数据加载中...
2025/06/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/20

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/06/20

重要事件披露

Form 8-K - Current report
2025/06/05

重要事件披露

Form 8-K - Current report
2025/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/04/25

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/10

重要事件披露

Form 8-K - Current report
2025/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/18

重要事件披露

Form 8-K - Current report
2024/12/27

重要事件披露

Form 8-K - Current report
2024/11/27

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/12

SEC问询函

Form CORRESP - Correspondence